BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31852781)

  • 1. P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.
    Soare AY; Malik HS; Durham ND; Freeman TL; Alvarez R; Patel F; Satija N; Upadhyay C; Hioe CE; Chen BK; Swartz TH
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
    Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
    J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.
    Soare AY; Durham ND; Gopal R; Tweel B; Hoffman KW; Brown JA; O'Brien M; Bhardwaj N; Lim JK; Chen BK; Swartz TH
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30305360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
    Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.
    Marin M; Du Y; Giroud C; Kim JH; Qui M; Fu H; Melikyan GB
    Assay Drug Dev Technol; 2015 Apr; 13(3):155-66. PubMed ID: 25871547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the SOS (A501C/T605C) and DS (I201C/A433C) Disulfide Bonds on HIV-1 Membrane Envelope Glycoprotein Conformation and Function.
    Nguyen HT; Alsahafi N; Finzi A; Sodroski JG
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the N-terminal segment of CCR5 in HIV-1 Env-mediated membrane fusion and the mechanism of virus adaptation to CCR5 lacking this segment.
    Melikyan GB; Platt EJ; Kabat D
    Retrovirology; 2007 Aug; 4():55. PubMed ID: 17686153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
    Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
    J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
    Joshi VR; Newman RM; Pack ML; Power KA; Munro JB; Okawa K; Madani N; Sodroski JG; Schmidt AG; Allen TM
    PLoS Pathog; 2020 May; 16(5):e1008577. PubMed ID: 32392227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
    Alsahafi N; Debbeche O; Sodroski J; Finzi A
    PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HIV-1 envelope-dependent membrane fusion by serum antilymphocyte autoantibodies is associated with low plasma viral load.
    Ruiz-Rivera MB; Gómez-Icazbalceta G; Vélez-Alavez M; Viveros-Rogel M; Pérez-Patrigeon S; Lamoyi E; Llorente L; Núñez-Álvarez CA; Huerta L
    Immunol Lett; 2019 Jul; 211():33-40. PubMed ID: 31059733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERINC5 Inhibits HIV-1 Infectivity by Altering the Conformation of gp120 on HIV-1 Particles.
    Featherstone A; Aiken C
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32796070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.
    Mediouni S; Jablonski JA; Tsuda S; Barsamian A; Kessing C; Richard A; Biswas A; Toledo F; Andrade VM; Even Y; Stevenson M; Tellinghuisen T; Choe H; Cameron M; Bannister TD; Valente ST
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions.
    Murakami T; Freed EO
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):343-8. PubMed ID: 10618420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.